Woman's Hospital Tested New Postpartum Hemorrhage Monitor

Baton Rouge medical staff are evaluating the Oli wearable monitor to help predict potential birth complications.

Updated on Sept. 25, 2026 in Pregnancy

Bold vector editorial illustration of a circular wearable medical sensor on a clean clinical surface, representing maternal healthcare innovation. — Woman's Hospital in Baton Rouge is participating in a clinical study to evaluate the Oli wearable monitor, an AI-powered device developed to help medical staff predict and prevent postpartum hemorrhage complications. AI Illustration. Upload story photo >

Live Poll

Do you believe AI-driven wearable monitors are an effective way to improve maternal health outcomes?

Woman's Hospital in Baton Rouge has joined a clinical study to test the Oli wearable monitor, a device designed to detect risks for postpartum hemorrhage. The sensor aims to identify complications that lead to preventable maternal death.

Why it matters

Current clinical practices struggle to accurately predict postpartum hemorrhage, a leading cause of maternal mortality. This new technology uses AI to analyze uterine fatigue data during labor to catch these issues before they become life-threatening.

The Oli monitor is a wearable belly sensor that tracks minute-by-minute data during labor. The ongoing clinical trial aims to enroll 1,000 participants to refine predictive capabilities.

The players

Woman's Hospital

This Baton Rouge medical facility is one of five U.S. sites participating in the Oli wearable monitor clinical trial.

Baymatob

Based in Australia, this AI-guided maternal and fetal diagnostics company designed the Oli wearable sensor.

The details

The Oli monitor, developed by the Australian firm Baymatob, provides continuous data analysis during the labor process to detect signs of impending hemorrhage. By identifying uterine fatigue early, medical teams hope to intervene more effectively for patients during the critical 24-hour window following birth.

2026 is the expected year for trial completion and FDA submission.

Culture Shift

The integration of AI-driven wearable technology reflects a broader shift toward proactive, data-heavy maternal monitoring to address high-risk obstetric outcomes. This development marks a move away from legacy reactive protocols that have historically failed to predict hemorrhage in laboring patients.

Local expectant mothers may be offered the opportunity to participate in the study while laboring at the hospital. These advancements could eventually lower the regional hemorrhage rate, providing patients with safer monitoring experiences during delivery.

The takeaway

The deployment of the Oli monitor signals a new standard of care where AI is used to provide real-time updates during labor. Patients should discuss current clinical monitoring options with their providers to understand how these technologies may influence their birth plans.